Showing results (211-220 of 497) with videos related to
Sort By:
Pageof 50
Archives of Disease in Childhood|August 11, 2017
Diagnostic delay in Canadian children with inflammatory bowel disease is more common in Crohn's disease and associated with decreased heightAmanda Ricciuto, Jennifer R Fish, Diane E Tomalty, et al.Gastro Hep Advances|August 12, 2024
Body Surface Area-Based Dosing of Infliximab is Superior to Standard Weight-Based Dosing in Children With Very Early Onset Inflammatory Bowel DiseaseLorraine Stallard, Karen Frost, Nathaniel Frost, et al.Gut|May 23, 2014
Early endoscopic, laboratory and clinical predictors of poor disease course in paediatric ulcerative colitisAmir Schechter, Christopher Griffiths, Juan Cristóbal Gana, et al.Journal of Clinical Gastroenterology|October 17, 2025
Effectiveness of an Infliximab Biosimilar vs. Originator in Inflammatory Bowel Diseases: A Noninferiority Nationwide Study From the epi-IIRNHadas Labrisch-Kaye, Rachel Buchuk, Yiska Weisband, et al.Frontiers in Pediatrics|November 15, 2021
Pediatric Gastrointestinal Endoscopy: Diagnostic Yield and Appropriateness of Referral Based on Clinical Presentation: A Pilot StudyTahel Fachler, Eyal Shteyer, Esther Orlanski Meyer, et al.Harefuah|October 22, 2018
[ESTABLISHING A REGISTRY FOR INFLAMMATORY BOWEL DISEASE PATIENTS IN MACCABI HEALTHCARE SERVICES - JOINT PROJECT BETWEEN HOSPITALS, EPI-IIRN GROUP AND COMMUNITY MEDICINE]Revital Kariv, Dan Turner, Joseph Rosenblum, et al.Digestive Endoscopy : Official Journal of the Japan Gastroenterological Endoscopy Society|June 11, 2013
Scalloping is a reliable endoscopic marker for celiac diseaseYair Kasirer, Dan Turner, Leora Lerman, et al.Journal of Pediatric Gastroenterology and Nutrition|July 10, 2012
Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelinesDan Turner, Arie Levine, Johanna C Escher, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 17, 2026
Tasty&Healthy exclusive whole food diet in asymptomatic children and young adults with biologically active Crohn's disease: the TASTI-E randomized controlled trialLuba Plotkin, Yonat Aharoni-Frutkoff, Daniel Pollak, et al.Gut|February 14, 2023
Immune response and barrier dysfunction-related proteomic signatures in preclinical phase of Crohn's disease highlight earliest events of pathogenesisHaim Leibovitzh, Sun-Ho Lee, Juan Antonio Raygoza Garay, et al.Pageof 50